Amazon's large and flashy investments stand out from those of its tech peers over the past year.Technologyread more
Consumer IPOs from Snap to Uber have been disappointing and serve as a reminder that private investors are making all the money.Technologyread more
China's currency has been an important barometer for progress in U.S.-Chinese trade talks, and right now it's signaling things aren't going well.Market Insiderread more
The company's comments Friday come after the White House said U.S.Trade Representative Robert Lighthizer will "address the threatened impairment" of national security from...Autosread more
While the prolonged fight has been devastating to an already-struggling agriculture industry, there's little indication Trump is paying a political price.Traderead more
Some analysts see streaming services like Netflix becoming hindered by one of the things that made them so popular in the first place — binge watching.Entertainmentread more
The 2019 PGA Championship wraps up on Sunday, May 19. Here's how much money the champion will earn.Earnread more
Apple CEO Tim Cook was the commencement speaker at Tulane University Saturday. In his speech, the tech executive focused on the importance of addressing climate change and...Power Playersread more
There is a shortfall of cybersecurity workers that could reach as high as 3.5 million unfilled roles by 2021. A start-up called Synack provides crowdsourced security, and...CNBC Disruptor 50read more
Yardeni Research's Edward Yardeni recommends investing in U.S. companies with exposure to China.Trading Nationread more
CNBC and SurveyMonkey's latest small business optimism index echoes that sentiment, finding 52 percent of small businesses say it's harder to find workers today than it was a...US Economyread more
The Trump administration is set to require drugmakers to include prices in advertisements, Politico reported Friday.
The proposal is slated to be introduced next week, Politico said, citing four people with knowledge of the plan. It's a key piece of President Donald Trump's blueprint to lower drug prices, which the administration unveiled in May.
"While we cannot comment on pending regulations, the President's 'American Patients First' blueprint to lower prescription drug prices and reduce out-of pocket costs clearly states that HHS is looking at options to require drug pricing transparency," Health and Human Services spokeswoman Caitlin Oakley told Politico. "It should not come as a surprise that this would require rulemaking."
However, it's unclear how effective including prices in prescription drug ads would be in lowering prices. Few patients actually pay the list price of a drug. How much they pay depends on a number of factors, including which insurance plan they have.
Trump has repeatedly chastised drug companies over the past few years. He once accused them of "getting away with murder."